Preotease/Cathepsin-Mediated Apoptosis in COPD
Preotease/Cathepsin-Mediated Apoptosis in COPD
批准号:
7251993
负责人:
Jack A Elias
金额:
$38.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2009-06-30
关键词:
AddressApoptosisBiological ModelsCCR5 geneCXCR3 geneCaspaseCaspase-1CathepsinsCellsCessation of lifeChronicChronic BronchitisChronic Obstructive Airway DiseaseCigaretteCigarette smoke-induced emphysemaClinicalDNA DamageDiseaseDisease ProgressionEndopeptidasesEpithelialEpithelial CellsEventFeedbackGenerationsGeneric DrugsGenesGrowthInflammationInflammatory ResponseInjuryInterferon Type IIInterferonsInterleukin-1Interleukin-12Interleukin-18InterventionLinkLungLung diseasesMatrix MetalloproteinasesMediatingMediator of activation proteinMedicalMitochondriaModelingMolecularMusNumbersOrganPathogenesisPathway interactionsPeptide HydrolasesPlayProcessProtease InhibitorProtein OverexpressionProteolysisPulmonary EmphysemaRegulationRoleSmokeSyndromeSystemTestingTimeTissuesTransgenic ModelTransgenic Organismschemokinecigarette smoke-inducedcigarette smokingcigarette smokingconceptcytokinedefined contributionnovelreceptorresponseresponse to injurytheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) includes emphysema and chronic bronchitis. It is a pressing clinical problem and a profound unmet medical need. A number of theories of emphysema pathogenesis have been proposed. The "protease/ antiprotease" hypothesis contends that the normal lung is protected by an "antiprotease shield" and that emphysema is caused by an increase in proteases and/or a decrease in antiproteases. It has been speculated that the Th1 inflammation in COPD is responsible for these alterations. More recently, structural cell apoptosis has been documented in emphysema. The mechanism(s) of Th1 induction of protease/ antiprotease alterations is poorly understood. Importantly, the mechanism(s) by which Th1 responses induce tissue injury and destruction, in the lung or other organs, have also not been defined. Our studies demonstrate that cigarette smoke (CS) induces emphysema via an IFN-y-dependent mechanism and that IFN-y causes emphysema via a novel cathepsin-mediated epithelial cell apoptosis/DNA injury (CMEA) pathway. They also demonstrated that CMEA participates in a positive feedback loop that augments inflammation and protease burden. We hypothesize that: (1) IFN-y plays a critical role in the pathogenesis of pulmonary emphysema. (2) IFN-y induces emphysema via a novel CMEA response that is induced by early growth response gene 1 (Egr-1) and the extrinsic and intrinsic apoptosis pathways. (3) CMEA plays a central role in a caspase-11 and caspase-1-dependent amplification loop that regulates tissue inflammation and protease burden. We will test this hypothesis and address the mechanisms of-Th1-induced tissue destruction with the following aims. Aim 1: Characterize the alterations in the IFN-y system and the role(s) of these alterations in the pathogenesis of CS and IFN-y-induced emphysema. Aim 2: Characterize the cathepsin system responses in CS-exposed and IFN-y Tg mice and their role(s) in the pathogenesis of pulmonary apoptosis, injury and emphysema. Aim 3: Define the roles of Egr-1, the extrinsic and intrinsic apoptosis pathways and terminal effector caspases in the pathogenesis of IFN-y and CS-Induced pulmonary apoptosis, injury and emphysema. Aim 4: Define the contribution of and mechanism by which CMEA regulates inflammation and protease burden in CS-exposed and IFN-y Tg mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential Roles of Chi3l1 and its receptors in COPD and IPF
-
批准号:10172313
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2013
-
负责人:Jack A Elias
-
依托单位:
Differential Roles of Chi3l1 and its receptors in COPD and IPF
-
批准号:10636903
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2013
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8499409
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8320196
-
项目类别:
-
资助金额:$65.81万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8818109
-
项目类别:
-
资助金额:$63.38万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
-
批准号:8138083
-
项目类别:
-
资助金额:$66.2万
-
财政年份:2011
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:7783229
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8402992
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8789047
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8015265
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
BRP-39/YKL-40 in Th2 Inflammation and Asthma
-
批准号:8207985
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2010
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:7124655
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:7474751
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:7272691
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Preotease/Cathepsin-Mediated Apoptosis in COPD
-
批准号:6966981
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Preotease/Cathepsin-Mediated Apoptosis in COPD
-
批准号:7450972
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
-
批准号:7907801
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
AMCase and BRP-39 in Th2 Inflammation and Asthma
-
批准号:6960185
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
-
批准号:7731970
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
Preotease/Cathepsin-Mediated Apoptosis in COPD
-
批准号:7089811
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2005
-
负责人:Jack A Elias
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: